• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The IARC Monographs: Updated Procedures for Modern and Transparent Evidence Synthesis in Cancer Hazard Identification.IARC 专著:癌症危险识别中现代透明证据综合的更新程序。
J Natl Cancer Inst. 2020 Jan 1;112(1):30-37. doi: 10.1093/jnci/djz169.
2
The Monographs Programme of the International Agency for Research on Cancer. A brief history of its Preamble.国际癌症研究机构专著计划。前言简史。
ALTEX. 2022;39(3):443–450. doi: 10.14573/altex.2004081. Epub 2021 Jun 16.
3
IARC Workshop on the Key Characteristics of Carcinogens: Assessment of End Points for Evaluating Mechanistic Evidence of Carcinogenic Hazards.国际癌症研究机构致癌物关键特性研讨会:评估用于评价致癌危害机制证据的终点指标
Environ Health Perspect. 2025 Feb;133(2):25001. doi: 10.1289/EHP15389. Epub 2025 Feb 3.
4
Recommendations for further revisions to improve the International Agency for Research on Cancer (IARC) Monograph program.进一步修订以改进国际癌症研究机构(IARC)专论计划的建议。
Regul Toxicol Pharmacol. 2020 Jun;113:104639. doi: 10.1016/j.yrtph.2020.104639. Epub 2020 Mar 5.
5
Critical reviews of exposure assessment in carcinogenic hazard identification: the IARC experience.致癌危险识别中暴露评估的批判性评论:IARC 的经验。
Occup Environ Med. 2024 Aug 16;81(7):366-372. doi: 10.1136/oemed-2023-109277.
6
IARC monographs: 40 years of evaluating carcinogenic hazards to humans.国际癌症研究机构专论:对人类致癌风险评估的40年
Environ Health Perspect. 2015 Jun;123(6):507-14. doi: 10.1289/ehp.1409149. Epub 2015 Feb 24.
7
Use of carcinogenicity bioassays in the IARC monographs.国际癌症研究机构专论中致癌性生物测定的应用。
Ann N Y Acad Sci. 2006 Sep;1076:592-600. doi: 10.1196/annals.1371.014.
8
Prevention, ethics and science: lessons from Lorenzo Tomatis.预防、伦理与科学:洛伦佐·托马蒂斯的经验教训
Ann Ist Super Sanita. 2008;44(1):8-12.
9
IARC monographs, industry influence, and upgrading, downgrading, and under-grading chemicals: a personal point of view. International Agency for Research on Cancer.国际癌症研究机构专论、行业影响以及化学物质的升级、降级和评级不足:个人观点。国际癌症研究机构
Int J Occup Environ Health. 2002 Jul-Sep;8(3):249-70. doi: 10.1179/107735202800338795.
10
Ten Years of Using Key Characteristics of Human Carcinogens to Organize and Evaluate Mechanistic Evidence in IARC Monographs on the Identification of Carcinogenic Hazards to Humans: Patterns and Associations.利用人类致癌物关键特征对国际癌症研究机构关于对人类致癌危害识别的专论中的机制证据进行组织和评估的十年:模式与关联
bioRxiv. 2023 Jul 12:2023.07.11.548354. doi: 10.1101/2023.07.11.548354.

引用本文的文献

1
Acute Promyelocytic Leukemia in a Patient With Sickle Cell Hemoglobin D Disease: A Case Report.镰状细胞血红蛋白D病患者的急性早幼粒细胞白血病:一例报告
Cureus. 2025 Jul 8;17(7):e87513. doi: 10.7759/cureus.87513. eCollection 2025 Jul.
2
The key characteristics concept.关键特征概念。
Curr Opin Toxicol. 2025 Mar;41. doi: 10.1016/j.cotox.2024.100515.
3
Mapping assays to the key characteristics of carcinogens to support decision-making.将检测方法与致癌物的关键特性进行映射以支持决策制定。
Database (Oxford). 2025 Apr 22;2025. doi: 10.1093/database/baaf026.
4
When Occupational Cancer Recognition Falters.当职业性癌症识别出现问题时。
Med Lav. 2025 Apr 17;116(2):16997. doi: 10.23749/mdl.v116i2.16997.
5
Bioactives derived from Brazilian native flora with antimicrobial and anticancer activity.源自巴西本土植物群且具有抗菌和抗癌活性的生物活性物质。
BMC Complement Med Ther. 2025 Mar 11;25(1):102. doi: 10.1186/s12906-025-04787-0.
6
Carcinogenicity assessment: "modern toxicology" considerations from experience in the evaluation of a carbon nanotube.致癌性评估:基于碳纳米管评估经验的“现代毒理学”考量
J Occup Health. 2025 Jan 7;67(1). doi: 10.1093/joccuh/uiaf013.
7
IARC Workshop on the Key Characteristics of Carcinogens: Assessment of End Points for Evaluating Mechanistic Evidence of Carcinogenic Hazards.国际癌症研究机构致癌物关键特性研讨会:评估用于评价致癌危害机制证据的终点指标
Environ Health Perspect. 2025 Feb;133(2):25001. doi: 10.1289/EHP15389. Epub 2025 Feb 3.
8
Urology on a changing planet: links between climate change and urological disease.变化中的星球上的泌尿学:气候变化与泌尿系统疾病之间的联系。
Nat Rev Urol. 2025 Apr;22(4):208-222. doi: 10.1038/s41585-024-00979-4. Epub 2025 Jan 28.
9
Update on Occupational Cancer for Better Cancer Prevention and Control.职业性癌症最新进展:助力更好的癌症预防与控制
Asian Pac J Cancer Prev. 2024 Dec 1;25(12):4465-4476. doi: 10.31557/APJCP.2024.25.12.4465.
10
Occupational Benzene Exposure and Lung Cancer in Human Studies: A Systematic Review and Meta-Analysis.职业性苯暴露与人类肺癌研究:一项系统评价与荟萃分析
Environ Health Perspect. 2024 Dec;132(12):126001. doi: 10.1289/EHP15086. Epub 2024 Dec 4.

本文引用的文献

1
Key Characteristics Approach to Carcinogenic Hazard Identification.关键特征方法在致癌危害识别中的应用。
Chem Res Toxicol. 2018 Dec 17;31(12):1290-1292. doi: 10.1021/acs.chemrestox.8b00321. Epub 2018 Dec 6.
2
Software Tools to Facilitate Systematic Review Used for Cancer Hazard Identification.软件工具可促进癌症危害识别的系统评价。
Environ Health Perspect. 2018 Oct;126(10):104501. doi: 10.1289/EHP4224.
3
Application of the key characteristics of carcinogens in cancer hazard identification.致癌物关键特征在癌症危害识别中的应用。
Carcinogenesis. 2018 Apr 5;39(4):614-622. doi: 10.1093/carcin/bgy031.
4
Moving forward in carcinogenicity assessment: Report of an EURL ECVAM/ESTIV workshop.迈向致癌性评估的新进程:EURL ECVAM/ESTIV 研讨会报告。
Toxicol In Vitro. 2017 Dec;45(Pt 3):278-286. doi: 10.1016/j.tiv.2017.09.010. Epub 2017 Sep 12.
5
A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicals.一种针对内分泌干扰化学物质的系统评价与综合评估(SYRINA)的提议框架。
Environ Health. 2016 Jul 14;15(1):74. doi: 10.1186/s12940-016-0156-6.
6
Study sensitivity: Evaluating the ability to detect effects in systematic reviews of chemical exposures.研究敏感性:在化学暴露系统评价中评估检测效应的能力。
Environ Int. 2016 Jul-Aug;92-93:605-10. doi: 10.1016/j.envint.2016.03.017. Epub 2016 May 5.
7
The Next Generation of Risk Assessment Multi-Year Study-Highlights of Findings, Applications to Risk Assessment, and Future Directions.下一代风险评估多年研究——研究结果亮点、在风险评估中的应用及未来方向
Environ Health Perspect. 2016 Nov;124(11):1671-1682. doi: 10.1289/EHP233. Epub 2016 Apr 19.
8
Key Characteristics of Carcinogens as a Basis for Organizing Data on Mechanisms of Carcinogenesis.致癌物的关键特征作为整理致癌机制数据的基础。
Environ Health Perspect. 2016 Jun;124(6):713-21. doi: 10.1289/ehp.1509912. Epub 2015 Nov 24.
9
The Navigation Guide systematic review methodology: a rigorous and transparent method for translating environmental health science into better health outcomes.《导航指南》系统评价方法:一种将环境卫生科学转化为更好健康结果的严谨且透明的方法。
Environ Health Perspect. 2014 Oct;122(10):1007-14. doi: 10.1289/ehp.1307175. Epub 2014 Jun 25.
10
A systematic approach for identifying and presenting mechanistic evidence in human health assessments.一种在人类健康评估中识别和呈现机制性证据的系统方法。
Regul Toxicol Pharmacol. 2013 Nov;67(2):266-77. doi: 10.1016/j.yrtph.2013.08.005. Epub 2013 Aug 16.

IARC 专著:癌症危险识别中现代透明证据综合的更新程序。

The IARC Monographs: Updated Procedures for Modern and Transparent Evidence Synthesis in Cancer Hazard Identification.

机构信息

Colorado School of Public Health, CO.

Department of Veterinary Integrative Biosciences, Texas A&M University, College Station, TX.

出版信息

J Natl Cancer Inst. 2020 Jan 1;112(1):30-37. doi: 10.1093/jnci/djz169.

DOI:10.1093/jnci/djz169
PMID:31498409
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6968684/
Abstract

The Monographs produced by the International Agency for Research on Cancer (IARC) apply rigorous procedures for the scientific review and evaluation of carcinogenic hazards by independent experts. The Preamble to the IARC Monographs, which outlines these procedures, was updated in 2019, following recommendations of a 2018 expert advisory group. This article presents the key features of the updated Preamble, a major milestone that will enable IARC to take advantage of recent scientific and procedural advances made during the 12 years since the last Preamble amendments. The updated Preamble formalizes important developments already being pioneered in the Monographs program. These developments were taken forward in a clarified and strengthened process for identifying, reviewing, evaluating, and integrating evidence to identify causes of human cancer. The advancements adopted include the strengthening of systematic review methodologies; greater emphasis on mechanistic evidence, based on key characteristics of carcinogens; greater consideration of quality and informativeness in the critical evaluation of epidemiological studies, including their exposure assessment methods; improved harmonization of evaluation criteria for the different evidence streams; and a single-step process of integrating evidence on cancer in humans, cancer in experimental animals, and mechanisms for reaching overall evaluations. In all, the updated Preamble underpins a stronger and more transparent method for the identification of carcinogenic hazards, the essential first step in cancer prevention.

摘要

国际癌症研究机构 (IARC) 编写的专论采用严格的程序,由独立专家对致癌危害进行科学审查和评估。概述这些程序的 IARC 专论前言于 2019 年根据 2018 年专家咨询小组的建议进行了更新。本文介绍了更新前言的主要特点,这是一个重要的里程碑,将使 IARC 能够利用自上次前言修订以来 12 年来在科学和程序方面取得的最新进展。更新的前言使专论计划中已经率先开展的重要工作正式化。这些进展是在一个明确和加强的程序中推进的,该程序用于确定、审查、评估和整合证据,以确定人类癌症的原因。所采用的进展包括加强系统评价方法;根据致癌物的关键特征,更加重视机制证据;在对流行病学研究进行关键评估时,包括其暴露评估方法,更加重视质量和信息量;改进不同证据来源评估标准的协调;以及将人类癌症、实验动物癌症和达成总体评估的机制方面的证据整合到一个步骤中。总之,更新的前言为识别致癌危害提供了一种更强有力和更透明的方法,这是癌症预防的关键第一步。